13G Filing: Intracoastal Capital, LLC and Apricus Biosciences Inc. (APRI)

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Mitchell P. Kopin 0 281,730 0 281,730 281,730 2.2%
Daniel B. Asher 0 281,730 0 281,730 281,730 2.2%
Intracoastal Capital 0 281,730 0 281,730 281,730 2.2%

Page 1 of 9 – SEC Filing

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

SCHEDULE
13G

 

Under
the Securities Exchange Act of 1934

 

(Amendment
No. )*

 

Apricus
Biosciences, Inc.

(Name
of Issuer)

 

Common
Stock, $0.001 par value per share

(Title
of Class of Securities)

 

03832V307

(CUSIP
Number)

 

April
26, 2017

(Date
of Event Which Requires Filing of this Statement)

 

Check
the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

a.       ☐
Rule 13d-1(b)

b.       
Rule 13d-1(c)

c.       
Rule 13d-1(d)

 

*The
remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the
subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided
in a prior cover page.

 

The
information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section
18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

Page 1 of 9

Follow Seelos Therapeutics Inc. (NASDAQ:SEEL)